Philips (PHIA) Stock Price, Fundamentals & Analysis

Philips (PHIA) is a health technology company headquartered in Amsterdam, the Netherlands, founded in 1891 and listed on Euronext Amsterdam, where it is one of the better-known Euronext Amsterdam stocks. The company employs 63,670 people and operates through three segments: Diagnosis & Treatment, Connected Care, and Personal Health. Its portfolio includes diagnostic imaging solutions such as ultrasound, magnetic resonance imaging, computed tomography and diagnostic x-ray, plus image-guided therapy systems and devices, patient monitoring, enterprise informatics, and sleep and respiratory care. Philips also has a strategic alliance with WellSpan Health focused on advanced imaging and diagnostics technology.

What PHIA does

Philips develops and sells medical devices and health technology to hospitals and consumers across North America, Greater China and internationally. In practice, that ranges from imaging equipment used in hospitals (MRI, CT, x-ray, ultrasound) to monitoring systems in intensive care and personal health products. It sits in the Healthcare sector and the Medical Devices industry, alongside peers such as GN Store Nord (GN) in Denmark and, further afield in pharma, Sun Pharma (SUNPHARMA) in India or Ropharma SA (RPH) in Romania.

Key numbers explained

• Price: 21.87 EUR, up +1.91% today, with a 52-week range of 20.9 – 27.7 and a -6.7% change over the last 52 weeks.
• Market capitalisation of 21.38B EUR — the total market value of all shares, a quick way to gauge company size.
• Trailing P/E ratio of 19.2 means the share price equals about 19.2 times the last twelve months of earnings per share (1.14 EUR); the forward P/E of 13 is based on expected earnings instead.
• Dividend yield of 3.89% — annual dividends relative to the share price — with 75% of earnings paid out as dividends and an ex-dividend date of May 12, 2026.
• Revenue of 17.66B EUR over the trailing twelve months, growing just 0.5% year over year.
• Profit margin of 6.3% and operating margin of 14% show how much of each euro of revenue survives as profit.
• Return on equity of 10.2%, a price-to-book ratio of 1.87, and a debt-to-equity ratio of 65% describe profitability, valuation versus assets, and leverage.
• A beta of 0.91 suggests the stock has historically moved slightly less than the overall market.

What to watch

As a medical devices company, Philips' results typically depend on hospital equipment spending cycles, healthcare budgets, and the pace of adoption of imaging and monitoring technology. With revenue growth of only 0.5% year over year, investors often watch whether order intake and segment performance improve. The 75% payout ratio means dividends depend on earnings staying stable. Regulatory processes, product recalls and competition in medical imaging are general factors that affect this industry. The next earnings date is Nov 3, 2026, and the stock is also part of the broader AEX index context; you can compare it with other companies in the Stocks directory.